Search

Your search keyword '"Touré A."' showing total 10,873 results
Start Over Author "Touré A."
10,873 results on '"Touré A."'

4. Meta-analysis of data from four clinical trials in the ivory coast assessing the efficacy of two artemisinin-based combination therapies (artesunate-amodiaquine and artemether-lumefantrine) between 2009 and 2016

Author

Bedia-Tanoh, Akoua Valerie, Kassi, Kondo Fulgence, Toure, Offianan Andre, Assi, Serge Brice, Gnagne, Akpa Paterne, Adoubryn, Koffi Daho, Bissagnene, Emmanuel, Konate, Abibatou, Miezan, Jean Sebastien, Angora, Kpongbo Etienne, Vanga-Bosson, Henriette, Kiki-Barro, Pulcherie Christiane, Djohan, Vincent, Yavo, William, and Menan, Eby Ignace Herve

Published
2024

5. The Internet of Responsibilities-Connecting Human Responsibilities using Big Data and Blockchain

Author

Tang, Xuejiao, Qiu, Jiong, Zhang, Wenbin, Toure, Ibrahim, Zhang, Mingli, Messina, Enza, Xie, Xueping, Wang, Xuebing, and Yu, Sheng

Subjects
Computer Science - Computers and Society, Computer Science - Artificial Intelligence, Computer Science - Cryptography and Security
Abstract

Accountability in the workplace is critically important and remains a challenging problem, especially with respect to workplace safety management. In this paper, we introduce a novel notion, the Internet of Responsibilities, for accountability management. Our method sorts through the list of responsibilities with respect to hazardous positions. The positions are interconnected using directed acyclic graphs (DAGs) indicating the hierarchy of responsibilities in the organization. In addition, the system detects and collects responsibilities, and represents risk areas in terms of the positions of the responsibility nodes. Finally, an automatic reminder and assignment system is used to enforce a strict responsibility control without human intervention. Using blockchain technology, we further extend our system with the capability to store, recover and encrypt responsibility data. We show that through the application of the Internet of Responsibility network model driven by Big Data, enterprise and government agencies can attain a highly secured and safe workplace. Therefore, our model offers a combination of interconnected responsibilities, accountability, monitoring, and safety which is crucial for the protection of employees and the success of organizations.

Published
2023

8. Inaugural Editorial

Author

Albarracin, Dolores, Conway, Paul, Laurent, Sean, Laurin, Kristin, Manzi, Francesca, Petrocelli, John V, Rattan, Aneeta, Salvador, Cristina E, Stern, Chadly, Todd, Andrew, Touré-Tillery, Maferima, Wakslak, Cheryl, and Zou, Xi

Subjects
Clinical and Health Psychology, Social and Personality Psychology, Psychology, Behavioral and Social Science, Humans, Personality, Personality Disorders, Psychology, Social, Marketing, Cognitive Sciences, Social Psychology, Cognitive and computational psychology, Social and personality psychology
Abstract

The commencement of a new editorial tenure within the Journal of Personality and Social Psychology: Attitudes and Social Cognition (JPSP: ASC) provides an opportunity for reflection regarding the journal's core mission. The editors recognize that social psychology is at a crossroads due to competing demands that may have led to reduced submissions and posed challenges for previous editors in filling the journal's pages. Now, JPSP: ASC has been allotted more pages to allow for growth during this editorial term. Although this is desirable for the field, it adds to the pressure of identifying articles for publication given the difficulties filling the pages during previous editorial terms. As the premier outlet of social psychology since 1965, JPSP: ASC will retain its centrality if we increase submissions and publish more articles, while continuing to strive to communicate methodologically trustworthy, intellectually stimulating, and socially relevant research, in a responsible fashion. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

Published
2024

9. Human and livestock surveillance revealed the circulation of Rift Valley Fever Virus in Agnam, Northern Senegal, 2021

Author

Mhamadi, Moufid, Badji, Aminata, Barry, Mamadou Aliou, Ndiaye, El Hadji, Gaye, Alioune, Ndiaye, Mignane, Mhamadi, Moundhir, Toure, Cheikh Talibouya, Ndiaye, Oumar, Faye, Babacar, Diop, Boly, Ndiaye, Mamadou, Fall, Mathioro, Diouf, Andy Mahine, Sagne, Samba Niang, Loucoubar, Cheikh, Fausther-Bovendo, Hugues, Sall, Amadou Alpha, Kobinger, Gary, Faye, Ousmane, Diallo, Mawlouth, and Faye, Oumar

Published
2023

10. Preoperative mortality risk evaluation in abdominal surgical emergencies: development and internal validation of the NDAR score from a national multicenter audit in Senegal

Author

Ndong, Abdourahmane, Diallo, Adja Coumba, Togtoga, Lebem, Faye, Magatte, Faye, Pape Mamadou, Diouf, Ahmed, Sarr, Ndiamé, Niasse, Abdou, Faye, Aliou Coly, Mbaye, Cheikh Tidiane, Bah, Mamadou Saidou, Ndoye, Pape Djibril, Doukoure, Mohamed, Guira, Moussa, Ka, Cheikh Tidiane, Diouf, Bathie Massamba, Faye, Thierno, Tandian, Foulaké, Dialllo, Thierno Amadou Telly, Gaye, Modou, Yamingué, Ngueidio, Kama, Housseynou, Kazubwenge, Emmanuel, Thiam, Mbaye, Diack, Abdou Dahim, Ndiaye, Mamadou Arame, Babara, Abamou, Samb, Cheikh, Badji, Cheikh Hameth, Diouf, Christine Marie Joseph, Fall, Sidy Mouhamed Abdoulaye, Camara, Mamadouba, Faye, Julien Ibrahima, Niang, Abdou Khadre, Dieng, Pape Souleymane, Ndiaye, Ablaye, Dia, Diago Anta, Sow, Omar, Diop, Abib, Seye, Yacine, Sarr, Ibrahima Souleymane Sitor, Gueye, Mohamadou Lamine, Diao, Mohamed Lamine, Manyacka, Philipe, Amaye Diémé, Eugène Gaudens Prosper, Sall, Ibrahima, Fall, Oumar, Sow, Alamasso, Tendeng, Jacques Noel, Thiam, Ousmane, Seck, Mamadou, Diouf, Cheikh, Ka, Ibrahima, Touré, Alpha Oumar, Diop, Balla, Ba, Pape Ablaye, Diop, Pape Saloum, Cissé, Mamadou, Niang, Khadim, and Konaté, Ibrahima

Published
2024
Full Text
View/download PDF

14. Quality assessment of malaria microscopic diagnosis at the Aristide Le Dantec University Hospital of Dakar, Senegal, in 2020

Author

Garba, Mamane N., Dème, Awa B., Diongue, Khadim, Diédhiou, Younousse, Mbaye, Amadou M., Dia, NDèye M., Seck, N’Dèye A., Zoumarou, Daba, Ndiaye, Lamine, Yade, Mamadou S., Dièye, Baba, Sène, Aita, Tine, Abdoulaye, Touré, Mariama, Gadiaga, Nogaye, Fall, Awa, Ngom, Bassirou, Sow, Djiby, Ndiaye, Aliou, Keita, Astou, Ndiaye, Mame F., Gomis, Jules F., Diop, Nana F., Diallo, Guète, Ndiaye, Ibrahima M., Ba, Elhadj M., Bitèye, Omar, Ndiaye, Cheikh, Mbodji, Fama S. D., Ndiaye, Pape O., Ndiaye, Tolla, Gaye, Amy, Sy, Mouhamad, Ndiaye, Yaye D., Seck, Mame C., Ndiaye, Mouhamadou, Badiane, Aida S., Diallo, Mamadou A., and Ndiaye, Daouda

Published
2024
Full Text
View/download PDF

15. Reported antibiotic use among patients in the multicenter ANDEMIA infectious diseases surveillance study in sub-saharan Africa

Author

Wieters, Imke, Johnstone, Siobhan, Makiala-Mandanda, Sheila, Poda, Armel, Akoua-Koffi, Chantal, Abu Sin, Muna, Eckmanns, Tim, Galeone, Valentina, Kaboré, Firmin Nongodo, Kahwata, François, Leendertz, Fabian H., Mputu, Benoit, Ouedraogo, Abdoul-Salam, Page, Nicola, Schink, Susanne B., Touré, Fidèle Sounan, Traoré, Adjaratou, Venter, Marietjie, Vietor, Ann Christin, Schubert, Grit, and Tomczyk, Sara

Published
2024
Full Text
View/download PDF

20. Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial

Author

Schilling, William H. K., Mukaka, Mavuto, Callery, James J., Llewelyn, Martin J., Cruz, Cintia V., Dhorda, Mehul, Ngernseng, Thatsanun, Waithira, Naomi, Ekkapongpisit, Maneerat, Watson, James A., Chandna, Arjun, Nelwan, Erni J., Hamers, Raph L., Etyang, Anthony, Beg, Mohammad Asim, Sow, Samba, Yavo, William, Allabi, Aurel Constant, Basnyat, Buddha, Sharma, Sanjib Kumar, Amofa-Sekyi, Modupe, Yonga, Paul, Adler, Amanda, Yuentrakul, Prayoon, Cope, Tanya, Thaipadungpanit, Janjira, Rienpradub, Panuvit, Imwong, Mallika, Abdad, Mohammad Yazid, Blacksell, Stuart D., Tarning, Joel, Goudjo, Frejus Faustin, Dossou, Ange D., Konaté-Touré, Abibatou, Assi, Serge-Brice, Ouffoué, Kra, Nasronudin, Nasronudin, Rachman, Brian Eka, Romadhon, Pradana Zaky, Dewanto, Didi Darmahadi, Heryana, Made Oka, Novi, Theresia, Pasaribu, Ayodhia Pitaloka, Mutiara, Mutiara, Nasution, Miranda Putri Rahayu, Khairunnisa, Khairunnisa, Dalimunthe, Fauzan Azima, Airlangga, Eka, Fahrezzy, Akmal, Subronto, Yanri, Ananda, Nur Rahmi, Rahardjani, Mutia, Rimainar, Atika, Lucinde, Ruth Khadembu, Timbwa, Molline, Onyango, Otieno Edwin, Agutu, Clara, Akech, Samuel, Hamaluba, Mainga, Kipyego, Jairus, Ngachi, Obadiah, Haidara, Fadima Cheick, Traoré, Oumar Y., Diarra, François, Khanal, Basudha, Dahal, Piyush, Shrestha, Suchita, Rijal, Samita, Kabore, Youssouf, Adehossi, Eric, Guindo, Ousmane, Qamar, Farah Naz, Kazi, Abdul Momin, Woodrow, Charles J., Laird, Steven, Cheeba, Maina, Ayles, Helen, Cheah, Phaik Yeong, Taylor, Walter R. J., Batty, Elizabeth M., Chotivanich, Kesinee, Pukrittayakamee, Sasithon, Phumratanaprapin, Weerapong, von Seidlein, Lorenz, Dondorp, Arjen, Day, Nicholas P. J., and White, Nicholas J.

Subjects
Hydroxychloroquine -- Testing, Chloroquine -- Testing, Biological sciences
Abstract

Background Hydroxychloroquine (HCQ) has proved ineffective in treating patients hospitalised with Coronavirus Disease 2019 (COVID-19), but uncertainty remains over its safety and efficacy in chemoprevention. Previous chemoprevention randomised controlled trials (RCTs) did not individually show benefit of HCQ against COVID-19 and, although meta-analysis did suggest clinical benefit, guidelines recommend against its use. Methods and findings Healthy adult participants from the healthcare setting, and later from the community, were enrolled in 26 centres in 11 countries to a double-blind, placebo-controlled, randomised trial of COVID-19 chemoprevention. HCQ was evaluated in Europe and Africa, and chloroquine (CQ) was evaluated in Asia, (both base equivalent of 155 mg once daily). The primary endpoint was symptomatic COVID-19, confirmed by PCR or seroconversion during the 3-month follow-up period. The secondary and tertiary endpoints were: asymptomatic laboratory-confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection; severity of COVID-19 symptoms; all-cause PCR-confirmed symptomatic acute respiratory illness (including SARS-CoV-2 infection); participant reported number of workdays lost; genetic and baseline biochemical markers associated with symptomatic COVID-19, respiratory illness and disease severity (not reported here); and health economic analyses of HCQ and CQ prophylaxis on costs and quality of life measures (not reported here). The primary and safety analyses were conducted in the intention-to-treat (ITT) population. Recruitment of 40,000 (20,000 HCQ arm, 20,000 CQ arm) participants was planned but was not possible because of protracted delays resulting from controversies over efficacy and adverse events with HCQ use, vaccine rollout in some countries, and other factors. Between 29 April 2020 and 10 March 2022, 4,652 participants (46% females) were enrolled (HCQ/CQ n = 2,320; placebo n = 2,332). The median (IQR) age was 29 (23 to 39) years. SARS-CoV-2 infections (symptomatic and asymptomatic) occurred in 1,071 (23%) participants. For the primary endpoint the incidence of symptomatic COVID-19 was 240/2,320 in the HCQ/CQ versus 284/2,332 in the placebo arms (risk ratio (RR) 0.85 [95% confidence interval, 0.72 to 1.00; p = 0.05]). For the secondary and tertiary outcomes asymptomatic SARS-CoV-2 infections occurred in 11.5% of HCQ/CQ recipients and 12.0% of placebo recipients: RR: 0.96 (95% CI, 0.82 to 1.12; p = 0.6). There were no differences in the severity of symptoms between the groups and no severe illnesses. HCQ/CQ chemoprevention was associated with fewer PCR-confirmed all-cause respiratory infections (predominantly SARS-CoV-2): RR 0.61 (95% CI, 0.42 to 0.88; p = 0.009) and fewer days lost to work because of illness: 104 days per 1,000 participants over 90 days (95% CI, 12 to 199 days; p < 0.001). The prespecified meta-analysis of all published pre-exposure RCTs indicates that HCQ/CQ prophylaxis provided a moderate protective benefit against symptomatic COVID-19: RR 0.80 (95% CI, 0.71 to 0.91). Both drugs were well tolerated with no drug-related serious adverse events (SAEs). Study limitations include the smaller than planned study size, the relatively low number of PCR-confirmed infections, and the lower comparative accuracy of serology endpoints (in particular, the adapted dried blood spot method) compared to the PCR endpoint. The COPCOV trial was registered with ClinicalTrials.gov; number NCT04303507. Interpretation In this large placebo-controlled, double-blind randomised trial, HCQ and CQ were safe and well tolerated in COVID-19 chemoprevention, and there was evidence of moderate protective benefit in a meta-analysis including this trial and similar RCTs. Trial registration ClinicalTrials.gov NCT04303507; ISRCTN Registry ISRCTN10207947., Author(s): William H. K. Schilling 1,2,*, Mavuto Mukaka 1,2, James J. Callery 1,2, Martin J. Llewelyn 3,4, Cintia V. Cruz 1,2, Mehul Dhorda 1,2, Thatsanun Ngernseng 1, Naomi Waithira 1,2, [...]

Published
2024
Full Text
View/download PDF

21. Crimean-Congo hemorrhagic fever virus survey in humans, ticks, and livestock in Agnam (Northeastern Senegal) from February 2021 to March 2022

Author

Mhamadi, Moufid, Badji, Aminata, Dieng, Idrissa, Gaye, Alioune, Ndiaye, El Hadji, Ndiaye, Mignane, Mhamadi, Moundhir, Toure, Cheikh Talibouya, Mbaye, Mouhamed Rassoul, Barry, Mamadou Aliou, Ndiaye, Oumar, Faye, Babacar, Ba, Fatimata Amadou, Diop, Boly, Ndiaye, Mamadou, Fall, Mathioro, Sagne, Samba Niang, Fall, Gamou, Loucoubar, Cheikh, Fausther-Bovendo, Hugues, Sall, Amadou Alpha, Kobinger, Gary, Faye, Ousmane, Diallo, Mawlouth, and Faye, Oumar

Published
2022

22. Evaluating the effectiveness of a novel systematic screening approach for tuberculosis among individuals suspected or recovered from COVID-19: Experiences from Niger and Guinea

Author

Magassouba, Aboubacar Sidiki, Bassirou, Souleymane Mahamadou, Toure, Almamy Amara, Diallo, Boubacar Djelo, Alphazazi, Soumana, Cisse, Diao, Keita, Mohamed Sitan, Seyabatou, Elhadj Saidou, Bangoura, Adama Marie, Traore, Hugues Asken, Decroo, Tom, Campbell, Jonathon R, Veronese, Vanessa, and Merle, Corinne Simone Collette

Published
2022

24. Defining Collective Priorities: Research and Learning Agendas for Family Planning Across 6 Countries.

Author

Brittingham, Sarah, Zan, Trinity, Andoh, Kouakou, Aryal, Kabita, Chissano, Marcos, Ferguson, Olivia, Fotso, Jean, Harou, Issoufa, Khatri, Sangita, Kourouma, Kadidiatou, Kiwanuka, Suzanne, Lal, Bibek, Govo, Alda, Malkin, Morrisa, Mkandawire, Philip, Phiri, Mary, Olaro, Charles, Pryor, Shannon, Shrestha, Bhagawan, Thapa, Basant, Touré, Fatoumata, and Prata, Ndola

Subjects
Adolescent, Humans, Family Planning Services, Learning, Consensus, Cote dIvoire, Evidence Gaps
Abstract

Evidence should be the foundation for a well-designed family planning (FP) program, but existing evidence is rarely aligned with and/or synthesized to speak directly to FP programmatic needs. Based on our experience cocreating FP research and learning agendas (FP RLAs) in Côte dIvoire, Malawi, Mozambique, Nepal, Niger, and Uganda, we argue that FP RLAs can drive the production of coordinated research that aligns with national priorities.To cocreate FP RLAs, stakeholders across 6 countries conducted desk reviews of 349 documents and 106 key informant interviews, organized consultation meetings in each country to prioritize evidence gaps and generate research and learning questions, and, ultimately, formed 6 FP RLAs comprising 190 unique questions. We outline the process for consensus-driven development of FP RLAs and communicate the results of an analysis of the questions in each FP RLA across 4 technical areas: self-care, equity, high impact practices, and youth. Each question was categorized as a learning versus research question, the former indicating an opportunity to synthesize existing evidence and the latter to conduct new research to answer the question. Themes emerging from the data shed light on shared evidence gaps across the 6 countries. We argue that similarities and differences in the questions in each FP RLA reflect the unique implementation experience and context, as well as each countrys placement on the FP S-curve. Early uses of the FP RLAs include informing the development of FP costed implementation plans and FP2030 commitments. FP RLAs have also been discussed in multiple thematic working groups. For FP stakeholders, these FP RLAs represent a consensus-based agenda that can guide the generation and synthesis of evidence to answer each countrys most pressing questions, ultimately driving progress toward increasingly evidence-based programming and policy.

Published
2023

25. A Novel Approach For Generating Customizable Light Field Datasets for Machine Learning

Author

Huang, Julia, Smith, Toure, Patro, Aloukika, and Chhabra, Vidhi

Subjects
Computer Science - Computer Vision and Pattern Recognition, Computer Science - Artificial Intelligence, Computer Science - Graphics, I.3.6
Abstract

To train deep learning models, which often outperform traditional approaches, large datasets of a specified medium, e.g., images, are used in numerous areas. However, for light field-specific machine learning tasks, there is a lack of such available datasets. Therefore, we create our own light field datasets, which have great potential for a variety of applications due to the abundance of information in light fields compared to singular images. Using the Unity and C# frameworks, we develop a novel approach for generating large, scalable, and reproducible light field datasets based on customizable hardware configurations to accelerate light field deep learning research., Comment: 5 pages, 5 figures, accepted to and presented at MIT URTC Conference, and will be published in IEEE proceedings

Published
2022

28. Automated and Improved Detection of Cyber Attacks via an Industrial IDS Probe

Author

Touré, Almamy, Imine, Youcef, Delot, Thierry, Gallais, Antoine, Semnont, Alexis, Giraudo, Robin, Rannenberg, Kai, Editor-in-Chief, Soares Barbosa, Luís, Editorial Board Member, Carette, Jacques, Editorial Board Member, Tatnall, Arthur, Editorial Board Member, Neuhold, Erich J., Editorial Board Member, Stiller, Burkhard, Editorial Board Member, Stettner, Lukasz, Editorial Board Member, Pries-Heje, Jan, Editorial Board Member, Kreps, David, Editorial Board Member, Rettberg, Achim, Editorial Board Member, Furnell, Steven, Editorial Board Member, Mercier-Laurent, Eunika, Editorial Board Member, Winckler, Marco, Editorial Board Member, Malaka, Rainer, Editorial Board Member, Meyer, Norbert, editor, and Grocholewska-Czuryło, Anna, editor

Published
2024
Full Text
View/download PDF

29. A Digital Ecosystem for Improving Product Design

Author

Lefebvre, Sylvain, Lecointre, Michaël, Lardeux, Benoit, Guyader, Jean-Marie, Aubrun, Olivier, Touré, Birane, Jridi, Maher, Filipe, Joaquim, Editorial Board Member, Ghosh, Ashish, Editorial Board Member, Prates, Raquel Oliveira, Editorial Board Member, Zhou, Lizhu, Editorial Board Member, Chbeir, Richard, editor, Benslimane, Djamal, editor, Zervakis, Michalis, editor, Manolopoulos, Yannis, editor, Ngyuen, Ngoc Thanh, editor, and Tekli, Joe, editor

Published
2024
Full Text
View/download PDF

30. Men Who Have Sex with Both Men and Women in West Africa: Factors Associated with a High Behavioral Risk of Acquiring HIV from Male Partners and Transmission to Women (CohMSM ANRS 12324—Expertise France)

Author

Fiorentino, Marion, Coulibaly, Bakary, Couderc, Clotilde, Keita, Bintou Dembélé, Anoma, Camille, Dah, Elias, Mensah, Ephrem, Aka, Thomas Niamkey, Touré, Juste Rodrigue, Camara, Drissa, Kokouba, Anouwarsadat Rodolphe, Maradan, Gwenaëlle, Mora, Marion, Bourrelly, Michel, Riegel, Lucas, Rojas-Castro, Daniela, Spire, Bruno, Laurent, Christian, and Sagaon-Teyssier, Luis

Published
2024
Full Text
View/download PDF

33. Effect of anti-Ebola virus monoclonal antibodies on endogenous antibody production in survivors of Ebola virus disease in the Democratic Republic of the Congo: an observational cohort study

Author

Ahuka-Mundeke, Steve, Bisento-Ngafa, Nella, Bulabula-Penge, Junior, Danga-Yema, Bernice, Eddi-Atani, François, Kinganda-Lusamaki, Eddy, Nkuba-Ndaye, Antoine, Mambu Mbika, Fabrice, Kabamba Lungenyi, Gabriel, Matondo Kiamfumu, Meris, Mbala-Kingebeni, Placide, Mukadi-Bamuleka, Daniel, Muyembe-Tamfum, Jean-Jacques, Delaporte, Eric, Ayouba, Ahidjo, Boullin, Julie, Dilu-Keti, Angèle, Lacroix, Audrey, Peeters, Martine, Pelloquin, Raphael, Thaurignac, Guillaume, Tovar Sanchez, Tamara, Kitenge, Richard, Formenty, Pierre, Legand, Anaïs, Panzi-Kalunda, Eric, Kakule-Sadiki, Callixte, Kambale-Kasyamboko, Guillaume, Kambale-Sivihwa, Nelson, Kavira-Muhesi, Sheila, Kavoyo-Mbayayi, Eli, Kitsa-Mutsumbirwa, Divine, Mbelu-Matulu, Fyfy, Mulopo-Mukanya, Noella, Mumbere-Kalemekwa, Elias, Defao, Paluku-Salambongo, Grace, Ekoko, Touré, Abdoulaye, Diallo, Mamadou Saliou Kalifa, Dilu-Keti, Angele, Tovar-Sanchez, Tamara, Edidi-Atani, François, and Toure, Abdoulaye

Published
2024
Full Text
View/download PDF

41. Persistent carriage of subpatent Plasmodium falciparum parasites associated with clinical malaria in a low transmission area in Senegal

Author

Sambe, Babacar Souleymane, Sarr, Ibrahima, Diagne, Aissatou, Diatta, Arona Sabène, Faye, Joseph, Diagne, Nafissatou, Diaw, Serigne Ousmane Mbacké, Mbodj, Adja Fatou, Sané, Rokhaya, Wotodjo, Amélé Nyedzie, Diouf, Babacar, Thiam, Alassane, Diamanka, Arfang, Faye, Ngor, Sembène, Papa Mbacké, Sarr, Fatoumata Diene, Dia, Ibrahima, Vigan-Womas, Inès, Sokhna, Cheikh, Toure-Balde, Aissatou, and Niang, Makhtar

Published
2024
Full Text
View/download PDF

45. Cost-Effectiveness of HIV Screening in Emergency Departments: Results From the Pragmatic Randomized HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial

Author

Austin, Bryan, Cohen, Jacob, Easley, Jackie, Haider, Somiya, Hill, Peter, Henley, Mauren, Kelen, Gabor, Leathers, Maggie, Maliszewski, Barbara, Neira, Paula, Newton, Scott, Peterson, Stephen, Saheed, Mustapha, Signer, Danielle, Spaeth, Lucas, Tolson, Tina, Toerper, Matthew, Viertel, Valentina, Whalen, Maddie, Ancona, Rachel, Cronin, Catherine, Fernandez, Frank, Fichtenbaum, Carl, Gaffney, Cortney, Hamilton, Cathy, Hart, Kim, Hoskins, Dave, Kohrs, Sharon, Lindsell, Christopher, Miller, Chris, Punches, Brittany, Ruffner, Andrew, Rowan, Geri, Vance, Kim, Williams, Teresa, Bucossi, Meggan, Cantrill, Steve, Chavez, Angelica, Comeau, Ann, Daugherty, Tracy, Delgado, Alex, Doyle, Pamela, Esquivel, Roberto, Fassino, Maren, Finnegan, Kelly, Fliney, Greg, Freudig, Theresa, Fuhriman, Michael, Gillman, Mary, Kahl-Geiger, Stacey, Keating, Korina, Koerner, Jason, Laber, Karen, Lang, Meghan, Lyle, Carolynn, Makela, Kim, Maltby, Mary, Medina, David, Nielsen, Tanya, Ortiz, Alice, Paolucci, Angela, Pate, Don, Pippins, Michael, Roy, Steven, Searcey, John, Solot, Jerry, Stermer, Kelly, Stuart, Brian, Swanson, Melissa, Timkovich, Lauren, Toure, Zenia, Vogel, Lisa, Walker, Sommer, Weed, Diane, Weise, Julia, Wenke, Kerri, Wham, Courtney, Wilson, Michael, Wright, Jarrod, Zwakenberg, Melody, Alter, Harrison, Anderson, Erik, Campbell, Brendan, Chang, Grace, Chao, Connie, Ellis, Katie, Graffman, Sarah, Kron, Brynn, Lucas, Rebecca, McCarthy, Caitlin, Ng, Valerie, O’Dell, Christine, Peck, Jim, Petti, Mae, Pfeil, Sarah, Saechao, Feuy, Simon, Barry, Todorovic, Tamara, Tyree, Tonya, Haukoos, Jason, Hopkins, Emily, Campbell, Jonathan D., Lyons, Michael S., Rothman, Richard E., Hsieh, Yu-Hsiang, White, Douglas A.E., Trent, Stacy, Al-Tayyib, Alia A., Gardner, Edward M., Sabel, Allison L., and Rowan, Sarah E.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results